Rapid degradation of puromycyl peptides in hepatoma cells and reticulocytes.
D000818:Animals; D001798:Blood Proteins / Q000096:biosynthesis*; D002250:Carbon Radioisotopes; D006528:Carcinoma, Hepatocellular / Q000378:metabolism*; D002460:Cell Line; D002850:Chromatography, Gel; D003513:Cycloheximide / Q000494:pharmacology; D004355:Drug Stability; D007700:Kinetics; D007930:Leucine / Q000378:metabolism; D008113:Liver Neoplasms; D009363:Neoplasm Proteins / Q000096:biosynthesis*; D011691:Puromycin / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012156:Reticulocytes / Q000187:drug effects / Q000378:metabolism*; D013997:Time Factors
D001798:Blood Proteins; D002250:Carbon Radioisotopes; D009363:Neoplasm Proteins; D011691:Puromycin; D003513:Cycloheximide; D007930:Leucine